Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.
<h4>Purpose</h4>Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-α) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER)...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/97b99bc571c9494aaab336ed28b36050 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:97b99bc571c9494aaab336ed28b36050 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:97b99bc571c9494aaab336ed28b360502021-11-25T05:58:50ZImpaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis.1932-620310.1371/journal.pone.0108616https://doaj.org/article/97b99bc571c9494aaab336ed28b360502014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0108616https://doaj.org/toc/1932-6203<h4>Purpose</h4>Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-α) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER) stress and autophagy response that selectively down regulates the type I IFN-α receptor-1 (IFNAR1) and RBV transporters (CNT1 and ENT1), leading to IFN-α/RBV resistance. The goal of this study is to verify whether an increase in ER stress and autophagy response is also associated with the reduced expression of IFNAR1 and RBV transporters in chronic HCV-infected patients.<h4>Methods</h4>Primary human hepatocytes (PHH) were infected with cell culture grown HCV particles (JFH-ΔV3-Rluc). HCV replication was confirmed by the detection of viral RNA by RT-qPCR and HCV-core protein by Western blotting. The ER stress and autophagy response and expression of IFN receptors and RBV transporters in HCV infected PHH and liver tissues derived from patients were measured by Western blotting.<h4>Result</h4>HCV infection of PHH showed impaired expression of IFNAR1, IFNγR1 (Type II IFN receptor) and RBV transporters but not IL10Rβ (Type III IFN-λ receptor). ER stress markers (BiP, IRE1α and peIF2α) and autophagy response (LC3II, Beclin 1 and ATG5) were induced in HCV infected chronic liver disease (CLD) and LC patients. Liver biopsies (CLD) show a 50% reduced expression of IFNAR1 and RBV transporters. Furthermore, the expression of IFNAR1 and RBV transporters was impaired in almost all LC patients.<h4>Conclusion</h4>HCV infection induces ER stress and autophagy response in infected PHH and chronically infected liver tissues. The expression of IFNAR1, IFNγR1 and RBV transporters were significantly impaired in CLD and cirrhotic livers. Our study provides a potential explanation for the reduced response rate of IFN-α and RBV combination therapy in HCV infected patients with liver cirrhosis.Partha K ChandraFeyza GunduzSidhartha HazariRamazan KurtRajesh PanigrahiBret PoatDavid BruceAri J CohenHumberto E BohorquezIan CarmodyGeorge LossLuis A BalartTong WuSrikanta DashPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 9, p e108616 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Partha K Chandra Feyza Gunduz Sidhartha Hazari Ramazan Kurt Rajesh Panigrahi Bret Poat David Bruce Ari J Cohen Humberto E Bohorquez Ian Carmody George Loss Luis A Balart Tong Wu Srikanta Dash Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| description |
<h4>Purpose</h4>Chronic Hepatitis C Virus (HCV)-infected patients with liver cirrhosis (LC) respond poorly to interferon-alpha (IFN-α) and ribavirin (RBV) combination therapy, but the reason for this is unclear. We previously reported that HCV-infection induces endoplasmic reticulum (ER) stress and autophagy response that selectively down regulates the type I IFN-α receptor-1 (IFNAR1) and RBV transporters (CNT1 and ENT1), leading to IFN-α/RBV resistance. The goal of this study is to verify whether an increase in ER stress and autophagy response is also associated with the reduced expression of IFNAR1 and RBV transporters in chronic HCV-infected patients.<h4>Methods</h4>Primary human hepatocytes (PHH) were infected with cell culture grown HCV particles (JFH-ΔV3-Rluc). HCV replication was confirmed by the detection of viral RNA by RT-qPCR and HCV-core protein by Western blotting. The ER stress and autophagy response and expression of IFN receptors and RBV transporters in HCV infected PHH and liver tissues derived from patients were measured by Western blotting.<h4>Result</h4>HCV infection of PHH showed impaired expression of IFNAR1, IFNγR1 (Type II IFN receptor) and RBV transporters but not IL10Rβ (Type III IFN-λ receptor). ER stress markers (BiP, IRE1α and peIF2α) and autophagy response (LC3II, Beclin 1 and ATG5) were induced in HCV infected chronic liver disease (CLD) and LC patients. Liver biopsies (CLD) show a 50% reduced expression of IFNAR1 and RBV transporters. Furthermore, the expression of IFNAR1 and RBV transporters was impaired in almost all LC patients.<h4>Conclusion</h4>HCV infection induces ER stress and autophagy response in infected PHH and chronically infected liver tissues. The expression of IFNAR1, IFNγR1 and RBV transporters were significantly impaired in CLD and cirrhotic livers. Our study provides a potential explanation for the reduced response rate of IFN-α and RBV combination therapy in HCV infected patients with liver cirrhosis. |
| format |
article |
| author |
Partha K Chandra Feyza Gunduz Sidhartha Hazari Ramazan Kurt Rajesh Panigrahi Bret Poat David Bruce Ari J Cohen Humberto E Bohorquez Ian Carmody George Loss Luis A Balart Tong Wu Srikanta Dash |
| author_facet |
Partha K Chandra Feyza Gunduz Sidhartha Hazari Ramazan Kurt Rajesh Panigrahi Bret Poat David Bruce Ari J Cohen Humberto E Bohorquez Ian Carmody George Loss Luis A Balart Tong Wu Srikanta Dash |
| author_sort |
Partha K Chandra |
| title |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| title_short |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| title_full |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| title_fullStr |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| title_full_unstemmed |
Impaired expression of type I and type II interferon receptors in HCV-associated chronic liver disease and liver cirrhosis. |
| title_sort |
impaired expression of type i and type ii interferon receptors in hcv-associated chronic liver disease and liver cirrhosis. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/97b99bc571c9494aaab336ed28b36050 |
| work_keys_str_mv |
AT parthakchandra impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT feyzagunduz impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT sidharthahazari impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT ramazankurt impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT rajeshpanigrahi impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT bretpoat impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT davidbruce impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT arijcohen impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT humbertoebohorquez impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT iancarmody impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT georgeloss impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT luisabalart impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT tongwu impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis AT srikantadash impairedexpressionoftypeiandtypeiiinterferonreceptorsinhcvassociatedchronicliverdiseaseandlivercirrhosis |
| _version_ |
1718414356357578752 |